1. Home
  2. JHX vs BBIO Comparison

JHX vs BBIO Comparison

Compare JHX & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo James Hardie Industries plc (Ireland)

JHX

James Hardie Industries plc (Ireland)

HOLD

Current Price

$24.79

Market Cap

15.0B

Sector

Industrials

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$70.69

Market Cap

15.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JHX
BBIO
Founded
1888
2015
Country
Ireland
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0B
15.3B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
JHX
BBIO
Price
$24.79
$70.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
22
Target Price
$28.50
$79.91
AVG Volume (30 Days)
6.5M
2.8M
Earning Date
01-01-0001
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.09
EPS
N/A
N/A
Revenue
N/A
$221,902,000.00
Revenue This Year
$25.60
$128.68
Revenue Next Year
$15.24
$83.58
P/E Ratio
$122.05
N/A
Revenue Growth
N/A
2285.27
52 Week Low
$16.46
$28.33
52 Week High
$32.91
$84.94

Technical Indicators

Market Signals
Indicator
JHX
BBIO
Relative Strength Index (RSI) 58.28 42.72
Support Level $24.85 $72.82
Resistance Level $25.63 $76.81
Average True Range (ATR) 0.83 4.46
MACD 0.02 -0.22
Stochastic Oscillator 44.62 36.15

Price Performance

Historical Comparison
JHX
BBIO

About JHX James Hardie Industries plc (Ireland)

James Hardie is a manufacturer of fiber cement-based building products, selling primarily to the residential construction industry. North America is the primary geography, generating about 80% of group earnings. Here, it is the largest manufacturer of fiber cement, which is mainly used for exterior siding on houses. Following the Azek acquisition in 2025, it also produces wooden composite decking materials, siding trims, and accessories for outdoor areas including stair and deck railing. Businesses in Australia, New Zealand, and Europe, make up the rest of earnings.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: